Znanstveni rad - Izvorni znanstveni rad
SLC6A3, HTR2C and HTR6 Gene Polymorphisms and the Risk of Haloperidol-Induced Parkinsonism
Biomedicines, 10 (2022), 12; 3237. https://doi.org/10.3390/biomedicines10123237


Citirajte ovaj rad

Nedić Erjavec, G., Grubor, M., Živković, M., Božina, N., Šagud, M., Nikolac Perković, M. ... Švob Štrac, D. (2022). SLC6A3, HTR2C and HTR6 Gene Polymorphisms and the Risk of Haloperidol-Induced Parkinsonism. Biomedicines, 10. (12). doi: 10.3390/biomedicines10123237

Nedić Erjavec, Gordana, et al. "SLC6A3, HTR2C and HTR6 Gene Polymorphisms and the Risk of Haloperidol-Induced Parkinsonism." Biomedicines, vol. 10, br. 12, 2022. https://doi.org/10.3390/biomedicines10123237

Nedić Erjavec, Gordana, Mirko Grubor, Maja Živković, Nada Božina, Marina Šagud, Matea Nikolac Perković, Alma Mihaljević Peleš, Nela Pivac i Dubravka Švob Štrac. "SLC6A3, HTR2C and HTR6 Gene Polymorphisms and the Risk of Haloperidol-Induced Parkinsonism." Biomedicines 10, br. 12 (2022). https://doi.org/10.3390/biomedicines10123237

Nedić Erjavec, G., et al. (2022) 'SLC6A3, HTR2C and HTR6 Gene Polymorphisms and the Risk of Haloperidol-Induced Parkinsonism', Biomedicines, 10(12). doi: 10.3390/biomedicines10123237

Nedić Erjavec G, Grubor M, Živković M, Božina N, Šagud M, Nikolac Perković M, i sur.. SLC6A3, HTR2C and HTR6 Gene Polymorphisms and the Risk of Haloperidol-Induced Parkinsonism. Biomedicines [Internet]. 13.12.2022. [pristupljeno 09.10.2024.];10(12). doi: 10.3390/biomedicines10123237

G. Nedić Erjavec, et al., "SLC6A3, HTR2C and HTR6 Gene Polymorphisms and the Risk of Haloperidol-Induced Parkinsonism", Biomedicines, vol. 10, br. 12, Prosinac 2022. [Online]. Dostupno na: https://urn.nsk.hr/urn:nbn:hr:105:746134. [Citirano: 09.10.2024.]